Growth Metrics

Gilead Sciences (GILD) Income towards Parent Company (2009 - 2026)

Gilead Sciences posted quarterly Income towards Parent Company of $2.0 billion for Q1 2026, up 53.69% year-on-year from $1.3 billion in Q1 2025, and down 20.06% on a QoQ basis from $2.5 billion in Q4 2025.

Gilead Sciences (GILD) has 18 years of Income towards Parent Company data on file, last reported at $2.0 billion in Q1 2026.

  • For the quarter ending Q1 2026, Income towards Parent Company rose 53.69% year-over-year to $2.0 billion; the trailing twelve-month figure through Mar 2026 stood at $9.6 billion (up 60.3% YoY), and the FY2025 full-year result was $8.5 billion, up 1676.62% from the prior year.
  • Income towards Parent Company for Q1 2026 stood at $2.0 billion, down from $2.5 billion in the prior quarter.
  • Across five years, Income towards Parent Company topped out at $3.1 billion in Q3 2025 and bottomed at -$4.2 billion in Q1 2024.
  • The 5-year median for Income towards Parent Company is $1.6 billion (2024), against an average of $1.3 billion.
  • The widest annual swing landed in 2023, when Income towards Parent Company jumped 8100.0%; it then plunged 523.88% in 2024.
  • A 5-year view of Income towards Parent Company shows it stood at $1.6 billion in 2022, then declined by 13.29% to $1.4 billion in 2023, then climbed by 25.85% to $1.8 billion in 2024, then jumped by 41.86% to $2.5 billion in 2025, then declined by 20.06% to $2.0 billion in 2026.
  • The last three Income towards Parent Company figures came in at $2.0 billion (Q1 2026), $2.5 billion (Q4 2025), and $3.1 billion (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Novartis Ag 107,124,802.25 Bn 107,124,802.25 Bn -
2 Eli Lilly 969.00 Bn 963.72 Bn 16.22 Bn
3 Johnson & Johnson 539.46 Bn 517.41 Bn 15.96 Bn
4 AbbVie 376.92 Bn 367.57 Bn 10.78 Bn
5 Merck 285.00 Bn 279.35 Bn 12.09 Bn
6 Amgen 177.58 Bn 165.55 Bn 5.87 Bn
7 Gilead Sciences 163.22 Bn 155.50 Bn 5.52 Bn
8 Pfizer 145.86 Bn 133.09 Bn -1.21 Bn
9 Bristol Myers Squibb 111.90 Bn 101.44 Bn 8.07 Bn
10 Gsk 88.34 Bn 83.66 Bn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 2.02 Bn
Dec 31, 2025 2.53 Bn
Sep 30, 2025 3.05 Bn
Jun 30, 2025 1.96 Bn
Mar 31, 2025 1.32 Bn
Dec 31, 2024 1.78 Bn
Sep 30, 2024 1.25 Bn
Jun 30, 2024 1.62 Bn
Mar 31, 2024 -4.17 Bn
Dec 31, 2023 1.42 Bn
Sep 30, 2023 2.17 Bn
Jun 30, 2023 1.04 Bn
Mar 31, 2023 984.00 Mn
Dec 31, 2022 1.63 Bn
Sep 30, 2022 1.79 Bn
Jun 30, 2022 1.14 Bn
Mar 31, 2022 12.00 Mn
Dec 31, 2021 376.00 Mn
Sep 30, 2021 2.59 Bn
Jun 30, 2021 1.51 Bn
Mar 31, 2021 1.71 Bn
Dec 31, 2020 1.53 Bn
Sep 30, 2020 327.00 Mn
Jun 30, 2020 -3.46 Bn
Mar 31, 2020 1.43 Bn
Dec 31, 2019 576.00 Mn
Sep 30, 2019 -1.30 Bn
Jun 30, 2019 1.74 Bn
Mar 31, 2019 1.83 Bn
Dec 31, 2018 281.00 Mn
Sep 30, 2018 1.95 Bn
Jun 30, 2018 1.76 Bn
Mar 31, 2018 1.48 Bn
Dec 31, 2017 -3.73 Bn
Sep 30, 2017 2.30 Bn
Jun 30, 2017 2.66 Bn
Mar 31, 2017 2.22 Bn
Dec 31, 2016 2.62 Bn
Sep 30, 2016 2.83 Bn
Jun 30, 2016 2.92 Bn
Mar 31, 2016 3.57 Bn
Dec 31, 2015 4.11 Bn
Sep 30, 2015 4.06 Bn
Jun 30, 2015 4.15 Bn
Mar 31, 2015 3.92 Bn
Dec 31, 2014 3.07 Bn
Sep 30, 2014 2.43 Bn
Jun 30, 2014 3.31 Bn
Mar 31, 2014 1.91 Bn
Dec 31, 2013 411.46 Mn
Sep 30, 2013 476.35 Mn
Jun 30, 2013 516.23 Mn
Mar 31, 2013 477.47 Mn
Dec 31, 2012 518.23 Mn
Sep 30, 2012 524.52 Mn
Jun 30, 2012 624.81 Mn
Mar 31, 2012 387.06 Mn
Dec 31, 2011 533.27 Mn
Sep 30, 2011 737.54 Mn
Jun 30, 2011 742.46 Mn
Mar 31, 2011 647.30 Mn
Dec 31, 2010 626.37 Mn
Sep 30, 2010 702.16 Mn
Jun 30, 2010 709.13 Mn
Mar 31, 2010 852.09 Mn
Dec 31, 2009 1.51 Bn
Sep 30, 2009 670.48 Mn
Jun 30, 2009 569.15 Mn
Mar 31, 2009 586.58 Mn